Legal & General Group Plc Has $266.34 Million Position in Cigna Corporation (NYSE:CI)

Legal & General Group Plc increased its position in shares of Cigna Corporation (NYSE:CI) by 0.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,424,817 shares of the health services provider’s stock after purchasing an additional 9,921 shares during the quarter. Legal & General Group Plc owned 0.58% of Cigna worth $266,335,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CI. Capstone Investment Advisors Netherlands B.V. bought a new stake in Cigna in the second quarter valued at $106,000. Saratoga Research & Investment Management bought a new stake in Cigna in the third quarter valued at $112,000. Horan Capital Advisors LLC. bought a new stake in Cigna in the third quarter valued at $123,000. Parallel Advisors LLC lifted its stake in Cigna by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after buying an additional 307 shares during the last quarter. Finally, Acrospire Investment Management LLC lifted its stake in Cigna by 66.7% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock valued at $167,000 after buying an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 87.85% of the company’s stock.

CI has been the topic of a number of recent research reports. Citigroup raised their target price on Cigna from $198.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Jefferies Group raised their target price on Cigna from $221.00 to $231.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research upgraded Cigna from a “hold” rating to a “buy” rating and set a $214.00 target price on the stock in a research note on Monday, October 9th. Piper Jaffray Companies reiterated a “buy” rating and issued a $191.00 target price on shares of Cigna in a research note on Sunday, September 17th. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $185.00 price target on shares of Cigna in a report on Wednesday, August 9th. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $201.50.

In related news, insider Christopher J. Hocevar sold 8,387 shares of Cigna stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $200.32, for a total value of $1,680,083.84. Following the transaction, the insider now owns 12,363 shares of the company’s stock, valued at approximately $2,476,556.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Alan Muney sold 15,345 shares of Cigna stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the completion of the transaction, the executive vice president now directly owns 28,457 shares in the company, valued at approximately $5,714,165.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 36,203 shares of company stock worth $7,211,251. 1.30% of the stock is owned by corporate insiders.

Cigna Corporation (CI) opened at $204.12 on Wednesday. The stock has a market capitalization of $50,323.26, a PE ratio of 19.66, a P/E/G ratio of 1.56 and a beta of 0.50. Cigna Corporation has a fifty-two week low of $131.03 and a fifty-two week high of $212.46. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37.

Cigna (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.36 by $0.47. The firm had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. Cigna had a return on equity of 18.85% and a net margin of 5.74%. Cigna’s revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.94 earnings per share. analysts anticipate that Cigna Corporation will post 10.34 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/12/06/legal-general-group-plc-boosts-holdings-in-cigna-corporation-ci.html.

Cigna Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply